06 / 74 · 0:55 · Original AXON film
Thymalin
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
THYMALIN | Peptide mixture
Thymalin is a mixture of peptides isolated from thymus tissue. Its research asks how immune-cell development might be influenced. [1]
HUMAN CELLS IN A LAB
In one study, cultured human blood-forming stem cells changed several surface markers after exposure. The authors interpreted those changes as signs of differentiation. [1]
Cell markers ≠ patient outcomes
That experiment did not show fewer infections, longer life or reversal of immune ageing in patients. Older clinical reports exist, but strong claims require carefully controlled, independently replicated evidence. [1] [2]
Composition • controls • replication
Because thymalin is an extract, its identity and composition also matter. Keep this discussion at the level of experimental immunology rather than promising an immune reset. [1]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells →Primary human-cell culture study, not a human treatment trial
- Peptides of pineal gland and thymus prolong human life →Historical human clinical report; title is an author claim, not an established conclusion
